Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PRP for Chronic Patellar Tendinopathy
NCT01843504Phase 2Completed
- Sponsor
- University of Wisconsin–Madison
- Start
- Feb 2014
- Primary completion
- Feb 2024
- Modality
- Adoptive Cell Transfer
- Countries
- 1
01
Overview
Phase 2, randomised, single-blind trial of autologous platelet-rich plasma in patellar tendinopathy (2 arms), sponsored by University of Wisconsin–Madison. Primary endpoints: Victorian Institute of Sport Assessment-Patellar at 32 weeks, International Knee Documentation Committee at 32 weeks and 1 more. Started Feb 2014; status: completed.
02
Drugs
autologous platelet-rich plasma
03
Conditions
patellar tendinopathy
Beyond the preview
Go deeper on NCT01843504.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01843504.